Ann: AnteoTech Signs Australian Distribution Agreement for EuGeni, page-125

The more I think about the saliva sampling issue the more I believe it has become a complete red herring on here. Do I think it will be great if the Indian live patient trials prove up the saliva use case? Sure. Do I believe Eugeni's adoption is completely reliant on it? No, not at all. The point is Eugeni is highly sensitive to the virus, top five in the world for a rapid test, with a fifteen minute result. The Eugeni reader can process sixty samples an hour. What capacity do you think the likes of Vietnam has to PCR test its population when there is a serious outbreak? That's a country with a huge tightly packed population. And they are beginning to struggle right now.



The thought that an Asian government such as Singapore's, for instance, would give the slightest stuff about your two seconds of discomfort while screening you at Changi airport is quite laughable when you really think about it. Have you seen how they deal with litterers or gum chewers? There is currently an opportunity for Anteo to sell the Eugeni platform in large numbers to Asia because the pandemic is currently very bad there. I personally don't see Biomed's task of selling our platform into the massive market that is Asia as being that hard at all. I'm very much looking forward to hearing more about yesterday's agreement with them in the coming quarterly along with a lot more... ellume, multiplex testing and batteries to name a few.